Aurinia Pharmaceuticals Inc. — Director's Dealing 2021

Feb 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-01-29

Reporting Person: Leversage Jill (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-29	Common Shares	P	400	$16.03	Acquired	400	Indirect
2021-01-29	Common Stock	P	1200	$16.03	Acquired	1200	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1000	Indirect

Footnotes

F1: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date.

F2: The shares were inadvertently reported as direct by the reporting person in the previously filed Form 3.